StockIQpro
NASDAQ:VIVS

VivoSim Labs, INC.

VivoSim Labs, INC.'s revenue fell 9.0% in fiscal 2026 to $131,000 while operating margin fell to −8768.7%. Free cash flow was −$10.8M, −8264.9% of revenue, and the diluted share count rose 76.8%.Summary generated from VivoSim Labs, INC.'s SEC filings. Latest annual report filed Jul 14, 2026.

Revenue (FY26)$131,000
Revenue growth−9.0%
Revenue, 5-yr CAGRn/a
Gross margin100.0%
Operating margin−8768.7%
Net margin−10567.2%
ROICn/a
Return on equity−294.8%
Debt / equityn/a
Free cash flow−$10.8M
FCF margin−8264.9%
Share count change+76.8%

Financials

Fiscal years, $M
Item20222023202420252026
Revenue20000
Operating income−11−18−15−13−11
Net income−11−17−15−2−14
Free cash flow−9−13−15−9−11

Recent filings

From SEC EDGAR

Peers

Biological products, (no diagnostic substances)